TY - JOUR AU - Colleoni, M. AU - Rocca, A. AU - Sandri, M. T. AU - Zorzino, L. AU - Masci, G. AU - Nole, F. AU - Peruzzotti, G. AU - Robertson, C. AU - Orlando, L. AU - Cinieri, S. PY - 2002 DA - 2002// TI - Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels JO - Ann Oncol VL - 13 UR - https://doi.org/10.1093/annonc/mdf013 DO - 10.1093/annonc/mdf013 ID - Colleoni2002 ER - TY - JOUR AU - Jemal, A. AU - Murray, T. AU - Samuels, A. AU - Ghafoor, A. AU - Ward, E. AU - Thun, M. J. PY - 2003 DA - 2003// TI - Cancer statistics, 2003 JO - CA Cancer J Clin VL - 53 UR - https://doi.org/10.3322/canjclin.53.1.5 DO - 10.3322/canjclin.53.1.5 ID - Jemal2003 ER - TY - JOUR AU - Crivellari, D. AU - Price, K. AU - Gelber, R. D. AU - Castiglione-Gertsch, M. AU - Rudenstam, C. M. AU - Lindtner, J. AU - Fey, M. F. AU - Senn, H. J. AU - Coates, A. S. AU - Collins, J. AU - Goldhirsch, A. PY - 2003 DA - 2003// TI - International Breast Cancer Study Group. Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.03.559 DO - 10.1200/JCO.2003.03.559 ID - Crivellari2003 ER - TY - JOUR PY - 2005 DA - 2005// TI - Effect of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials JO - Lancet VL - 365 UR - https://doi.org/10.1016/S0140-6736(05)66544-0 DO - 10.1016/S0140-6736(05)66544-0 ID - ref4 ER - TY - JOUR PY - 1988 DA - 1988// TI - Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomized trials among 28,896 women JO - New Engl J Med VL - 319 UR - https://doi.org/10.1056/NEJM198812293192601 DO - 10.1056/NEJM198812293192601 ID - ref5 ER - TY - JOUR PY - 1992 DA - 1992// TI - Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women JO - Lancet VL - 339 ID - ref6 ER - TY - JOUR PY - 1998 DA - 1998// TI - Tamoxifen for early breast cancer: an overview of the randomised trials JO - Lancet VL - 351 UR - https://doi.org/10.1016/S0140-6736(97)11423-4 DO - 10.1016/S0140-6736(97)11423-4 ID - ref7 ER - TY - JOUR AU - Fisher, B. AU - Dignam, J. AU - Wolmark, N. AU - DeCillis, A. AU - Emir, B. AU - Wickerham, D. L. AU - Bryant, J. AU - Dimitrov, N. V. AU - Abramson, N. AU - Atkins, J. N. PY - 1997 DA - 1997// TI - Tamoxifen and chemotherapy for lymph node negative, estrogen receptor-positive breast cancer JO - J Natl Cancer Inst VL - 89 UR - https://doi.org/10.1093/jnci/89.22.1673 DO - 10.1093/jnci/89.22.1673 ID - Fisher1997 ER -